指南与共识中毒与环境急症消化、代谢与肾脏急症

专家小组共识:改善阿片类使用障碍治疗参与和保留的州级政策

Expert Panel Consensus on State-Level Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder.
指南 / 共识 · JAMA Health Forum · 2022-09-02
一句话结论专家共识认为,便利阿片类使用障碍药物治疗和出狱人员自动加入医疗补助是高效可行的州级政策;强制性和附加要求政策价值低。

本研究采用改良德尔菲法,通过ExpertLens在线平台开展3轮调查,召集66名利益相关者(包括临床医生、社会服务从业者、成瘾研究者、卫生政策决策者、政策倡导者和有亲身经历者),分为两个专家小组,对14项假设的州级阿片类使用障碍治疗政策进行评分和讨论。有效性小组(n=29)评估政策对治疗参与、治疗保留、阿片类使用障碍缓解和阿片类过量死亡的影响;实施性小组(n=34)评估可接受性、可行性、可负担性和公平性。两个小组对所有条目均达成共识。专家认为便利获得阿片类使用障碍药物和出狱人员自动加入医疗补助这两项政策高度可实施且高效;中心-辐射型政策和向急诊科提供经济激励以促进治疗连接被评有效但面临可行性和可负担性障碍;强制性和对治疗个体附加要求的政策被视为低价值。结论认为这些发现可为各州采纳或取消相关政策提供急需的共识。

要点

  • 专家共识认为,便利获得阿片类使用障碍药物和出狱人员自动加入医疗补助这两项政策高度可实施且高效。
  • 中心-辐射型政策和向急诊科提供经济激励以促进治疗连接被评有效,但面临可行性和可负担性障碍。
  • 强制性和对阿片类使用障碍治疗个体附加要求的政策(如药物毒理学检测、咨询要求)被视为低价值,会降低治疗参与和保留、增加过量死亡和健康不平等。
  • 两个专家小组(有效性小组n=29,实施性小组n=34)对所有14项政策条目均达成共识。
  • 66名利益相关者通过3轮改良德尔菲法参与,使用RAND/UCLA适当性方法中的对称性调整百分位间距分析技术测量共识。

适用人群与场景

  • 美国州级政策制定相关的利益相关者,包括卫生保健临床医生、社会服务从业者、成瘾研究者、卫生政策决策者、政策倡导者和有亲身经历者。

诊断标准与关键阈值

  • 有效性小组(n=29)使用治疗参与、治疗保留、阿片类使用障碍缓解和阿片类过量死亡4个标准评估政策效果。
  • 实施性小组(n=34)使用可接受性、可行性、可负担性和公平性4个标准评估政策实施性。
  • 共识测量采用RAND/UCLA适当性方法中的对称性调整百分位间距分析技术。

研究设计与关键结果

  • 本研究为定性研究,使用ExpertLens在线平台进行3轮改良德尔菲法,召集66名利益相关者,分为有效性小组(n=29)和实施性小组(n=34),对14项假设的州级政策进行评分。
  • 两个小组对所有条目均达成共识。
  • 专家认为便利获得阿片类使用障碍药物和出狱人员自动加入医疗补助这两项政策高度可实施且高效。
  • 中心-辐射型政策和向急诊科提供经济激励以促进治疗连接被评有效,但面临可行性和可负担性障碍。
  • 强制性和对阿片类使用障碍治疗个体附加要求的政策(如药物毒理学检测、咨询要求)被视为低价值,会降低治疗参与和保留、增加过量死亡和健康不平等。

证据类型、等级与局限

  • 证据类型:改良德尔菲法专家共识(定性研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,本研究结果可为各州在应对阿片类过量危机时考虑采纳或取消相关政策提供急需的共识。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: In the US, recent legislation and regulations have been considered, proposed, and implemented to improve the quality of treatment for opioid use disorder (OUD). However, insufficient empirical evidence exists to identify which policies are feasible to implement and successfully improve patient and population-level outcomes.

OBJECTIVE: To examine expert consensus on the effectiveness and the ability to implement state-level OUD treatment policies.

EVIDENCE REVIEW: This qualitative study used the ExpertLens online platform to conduct a 3-round modified Delphi process to convene 66 stakeholders (health care clinicians, social service practitioners, addiction researchers, health policy decision-makers, policy advocates, and persons with lived experience). Stakeholders participated in 1 of 2 expert panels on 14 hypothetical state-level policies targeting treatment engagement and linkage, evidence-based and integrated care, treatment flexibility, and monitoring or support services. Participants rated policies in round 1, discussed results in round 2, and provided final ratings in round 3. Participants used 4 criteria associated with either the effectiveness or implementability to rate and discuss each policy. The effectiveness panel (n = 29) considered policy effects on treatment engagement, treatment retention, OUD remission, and opioid overdose mortality. The implementation panel (n = 34) considered the acceptability, feasibility, affordability, and equitability of each policy. We measured consensus using the interpercentile range adjusted for symmetry analysis technique from the RAND/UCLA appropriateness method.

FINDINGS: Both panels reached consensus on all items. Experts viewed 2 policies (facilitated access to medications for OUD and automatic Medicaid enrollment for citizens returning from correctional settings) as highly implementable and highly effective in improving patient and population-level outcomes. Participants rated hub-and-spoke-type policies and provision of financial incentives to emergency departments for treatment linkage as effective; however, they also rated these policies as facing implementation barriers associated with feasibility and affordability. Coercive policies and policies levying additional requirements on individuals with OUD receiving treatment (eg, drug toxicology testing, counseling requirements) were viewed as low-value policies (ie, decreasing treatment engagement and retention, increasing overdose mortality, and increasing health inequities).

CONCLUSIONS AND RELEVANCE: The findings of this study may provide urgently needed consensus on policies for states to consider either adopting or deimplementing in their efforts to address the opioid overdose crisis.

来源:JAMA Health Forum,查看原文。版权归原作者所有。

参考来源

  1. Smart R, Grant S, Gordon AJ, et al. Expert Panel Consensus on State-Level Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder. JAMA Health Forum. 2022. PMID: 36218944. doi:10.1001/jamahealthforum.2022.3285

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。